Featured Jobs
|
Senior Retirement Plan Administrator Daybright Financial
|
|
3(16) Plan Customer Liaison, Enrollments Compass
|
|
401k Generation
|
|
LucidHealth
|
|
July Business Services
|
|
July Business Services
|
|
ERISA Services Inc.
|
|
Compass
|
|
DWC (The 401k Experts)
|
|
Health Benefits Actuarial Consultant BPAS
|
|
Hilldrup.com
|
|
The Pension Design Group
|
|
PPS Pension Services
|
|
Senior 401k Plan Administrator FMI Retirement Services
|
|
Participant Services Representative West Coast BPAS
|
Free Publications
|
|
FTC's 'Landmark' Settlement with Pharmacy Benefit Manager Express Scripts: Impact on Pharma
King & Spalding 
Feb. 10, 2026 "Two remedial measures agreed to by ESI could particularly impact pharmaceutical manufacturers: [1] ESI's commitment not to discriminate between high and low list price versions of the same drug, and [2] delinking administrative fees paid by manufacturers from the list price.... [It] is unclear how ESI and the other PBMs will negotiate rebates for high and low list price drugs going forward." MORE >> |
| Please click here to report this link if it is broken (for example, if you see a "404 File Not Found" error message after you click on the linked news item's title). |
| An important word about authorship: BenefitsLink® created this link to the news item, but we are not the news item's author (unless expressly shown above). |